Round Table Services, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Round Table Services, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$696,000
-30.3%
339,3910.0%0.21%
-33.1%
Q2 2019$998,000
-21.2%
339,3910.0%0.31%
-29.5%
Q1 2019$1,266,000
-6.8%
339,3910.0%0.44%
-15.1%
Q4 2018$1,358,000
-28.0%
339,3910.0%0.52%
-20.2%
Q3 2018$1,887,000
+271.5%
339,391
+162.1%
0.64%
+277.2%
Q2 2018$508,000
-16.7%
129,5000.0%0.17%
-21.6%
Q1 2018$610,000
+14.0%
129,5000.0%0.22%
+17.8%
Q4 2017$535,000
-34.8%
129,5000.0%0.18%
-36.9%
Q3 2017$821,000
-19.1%
129,5000.0%0.29%
-20.6%
Q2 2017$1,015,000
+18.4%
129,5000.0%0.37%
+19.8%
Q1 2017$857,000
-4.7%
129,5000.0%0.31%
-15.8%
Q4 2016$899,000
-25.5%
129,5000.0%0.37%
-49.2%
Q3 2016$1,207,000
+0.8%
129,5000.0%0.72%
+6.8%
Q2 2016$1,197,000
+87.0%
129,500
+76.2%
0.68%
+68.8%
Q1 2016$640,000
+29.6%
73,5000.0%0.40%
+11.4%
Q4 2015$494,000
+16.2%
73,5000.0%0.36%
+15.1%
Q3 2015$425,000
-29.2%
73,5000.0%0.31%
-33.3%
Q2 2015$600,0000.0%73,5000.0%0.47%
-1.1%
Q1 2015$600,000
-11.1%
73,5000.0%0.47%
-11.1%
Q4 2014$675,000
-6.8%
73,5000.0%0.53%
-12.2%
Q3 2014$724,000
+78.8%
73,500
+96.0%
0.61%
+85.9%
Q2 2014$405,00037,5000.33%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders